Axogen, Inc. (AXGN)

NCM – Цена в реальном времени. Валюта: USD

49.13

+0.65 (1.34%)

Рынок открыт: Aug 12, 2026, 2:08 PM EDT

48.48

0.00 (0.00%)

Предыдущая сессия: Aug 11, 2026, 7:34 PM EDT

Обзор
Новости
График
Финансы
Дивиденды
Прогноз
Владельцы
Профиль

03.08.2026

Axogen: The Regulatory Moat Is Becoming A Commercial Flywheel

Axogen is transforming from a niche tissue supplier into a comprehensive nerve care platform, underpinned by FDA approval, stronger reimbursement, and expanding clinical evidence. Q2 2026 revenue grew 23.1% to $69.7M, with raised full-year guidance and strong elective market traction, though gross margin declined due to product mix and biologic costs. Avance's FDA biologic approval grants 12 years of exclusivity, regulatory credibility, and improved payer coverage, positioning AXGN as a category leader with significant market opportunity.

Видео

No Data

There is no data to display

Axogen, Inc. (AXGN)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Axogen, Inc. (AXGN)

Axogen: The Regulatory Moat Is Becoming A Commercial Flywheel

Видео

No Data

Axogen: The Regulatory Moat Is Becoming A Commercial Flywheel

Видео

No Data

Search stocks

Axogen, Inc. (AXGN)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Axogen, Inc. (AXGN)

Axogen: The Regulatory Moat Is Becoming A Commercial Flywheel

Видео

No Data

Axogen: The Regulatory Moat Is Becoming A Commercial Flywheel

Видео

No Data